A. Pohlmann

发表

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis

M. Arumugam, E. Latz, J. Trebicka, 2019, Zeitschrift für Gastroenterologie.

Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality

C. Strassburg, E. Latz, J. Trebicka, 2018, Hepatology.

Fat‐free muscle mass in magnetic resonance imaging predicts acute‐on‐chronic liver failure and survival in decompensated cirrhosis

C. Strassburg, J. Trebicka, A. Pohlmann, 2018, Hepatology.

Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality

C. Trautwein, C. Strassburg, J. Trebicka, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt

C. Strassburg, Stefan Fischer, J. Trebicka, 2019, Clinical and translational gastroenterology.

Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non‐obese HIV‐infected patients

J. Rockstroh, J. Trebicka, C. Boesecke, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation

C. Strassburg, J. Trebicka, G. Nickenig, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Fibroblast growth factor 21 is an early predictor of acute‐on‐chronic liver failure in critically ill patients with cirrhosis

J. Trebicka, P. Ryan, R. Schierwagen, 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Title: Fibroblast Growth Factor 21 is an Early Predictor of Acute-on-Chronic Liver Failure in Critically Ill Cirrhotic Patients. Short title: FGF21 predicts ACLF development

P. Ryan, R. Schierwagen, A. Pohlmann, 2018 .

Significant reduction of heart rate variability is a feature of cirrhosis acute decompensation most notable in acute-on-chronic liver failure and predicts 90-day mortality Running title: Loss of HRV in cirrhosis decompensation

Rajiv, Jalan, C. Strassburg, 2019 .

MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis

C. Strassburg, U. Spengler, J. Trebicka, 2017, Scientific Reports.

microRNA‐200a: A stage‐dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients

C. Strassburg, M. Odenthal, J. Rockstroh, 2017, Hepatology communications.

Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality

C. Strassburg, R. Jalan, J. Trebicka, 2019, Alimentary pharmacology & therapeutics.

Circulating microbiome in blood of different circulatory compartments

M. Arumugam, E. Latz, J. Trebicka, 2018, Gut.

Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma

C. Strassburg, J. Trebicka, A. Pohlmann, 2018, PloS one.

MYOSTATIN IS ASSOCIATED WITH THE PRESENCE AND DEVELOPMENT OF ACUTE-ON-CHRONIC LIVER FAILURE

J. Trebicka, R. Schierwagen, A. Pohlmann, 2023, JHEP Reports.

Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis

C. Strassburg, J. Trebicka, G. Nickenig, 2018, PloS one.